Sa1906 – Dose Escalation with Originator Infliximab is More Common Than Standard Dosing in Pediatric IBD – the Develop Experience
Griffiths, Anne M., Escher, Johanna C., Izanec, James L., Busse, Christopher, Wang, Yanli, Dubinsky, MarlaVolume:
156
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(19)37972-7
Date:
May, 2019
File:
PDF, 993 KB
english, 2019